IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sectoral Asset Management Inc

Q3 2025 Holdings

Filed 2025-11-14 | 82 holdings | $162.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Pfizer Inc(PFE)COM717081103$2.0M77,1501.2%
Danaher Corp(DHR)COM235851102$2.1M10,5751.3%
Boston Scientific(BSX)COM101137107$2.2M22,1261.3%
Gilead Sciences Inc(GILD)COM375558103$2.2M19,5501.3%
Regeneron Pharmctcls(REGN)COM75886F107$2.2M3,9681.4%
Abbott Labs(ABT)COM002824100$2.3M17,1981.4%
Beone Medicines LTD(ONC)SP ADR07725L102$2.5M7,2011.5%
Intuitive Surgic Inc(ISRG)COM NEW46120E602$2.6M5,7501.6%
Johnson & Johnson(JNJ)COM478160104$2.8M15,3001.8%
Argenx SE SPN ADR(ARGX)SP ADR04016X101$2.9M3,8901.8%
Instil BIO Inc(TIL)COM NEW45783C200$2.9M161,3801.8%
Amgen Inc(AMGN)COM031162100$2.9M10,3401.8%
Vertex Pharma(VRTX)COM92532F100$3.0M7,7151.9%
Tectonic Therapeutic(TECX)COM878972108$3.0M192,7701.9%
Palvella Therapeutic(PVLA)COM697947109$3.1M49,1151.9%
Zenas Biopharma(ZBIO)COM98937L105$3.4M152,0252.1%
Spdr Series Trust(XBI)S&P BIOTECH78464A870$3.4M34,0002.1%
MBX Biosciences Inc(MBX)COM55287L101$3.4M194,8982.1%
Abbvie Inc(ABBV)COM00287Y109$3.4M14,8002.1%
Ventyx Biosciences(VTYX)COM92332V107$3.4M1,107,2672.1%
Kura Oncology(KURA)COM50127T109$3.5M395,8722.2%
Solid Biosciences(SLDB)COM NEW83422E204$3.9M633,0522.4%
Oric Pharmaceuticals(ORIC)COM68622P109$3.9M328,6552.4%
Bicara Therapeutics(BCAX)COM055477103$4.2M266,4952.6%
Unitedhealth GRP Inc(UNH)COM91324P102$4.7M13,5452.9%
Immatics NV(IMTX)SHSN44445109$4.8M560,4942.9%
Arcus Biosciences(RCUS)COM03969F109$5.0M368,0703.1%
Shoulder Innovations(SI)COMMON STOCK82537J108$5.4M430,2823.3%
Anaptysbio Inc(ANAB)COM032724106$6.0M194,4853.7%
Structure Therapeutics(GPCR)SP ADR86366E106$6.2M221,8723.8%
ELI Lilly & Co(LLY)COM532457108$7.2M9,3764.4%
Contineum Therapeutics(CTNM)CL A21217B100$9.4M800,7875.8%
PreviousPage 2 of 2